Yarrow Bioscience Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +579.8% | +132.2% | -95.8% | +4,638.8% | -95.6% | -48.8% | -11.1% | +18.2% | +13.8% | |
| – | – | – | – | – | +297.7% | – | – | – | – | – | |
| – | – | +579.8% | +132.2% | -99.1% | +20,976.3% | -95.3% | -48.8% | -11.1% | +18.2% | +9.2% | |
| – | +285.3% | +157.7% | +82.7% | +1.5% | -19.0% | -55.1% | -5.9% | -11.3% | +89.8% | -37.8% | |
| – | +122.3% | +37.8% | +135.8% | +84.5% | – | – | – | -18.4% | -1.4% | -16.0% | |
| – | +225.7% | +127.7% | +90.7% | +17.0% | -405.5% | – | -12.7% | -14.6% | +48.7% | -31.4% | |
| – | – | – | – | – | – | -115.4% | – | – | – | – | |
| – | – | – | – | – | +376.7% | +27.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -97.1% | – | – | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.